Cargando…
Modification of implant surfaces to stimulate mesenchymal cell activation
BACKGROUND: The process of osteointegration, as key point has the activation of mesenchymal cells at implant-bone interspace, their differentiation into osteoblasts and connection between the implant surface and the surrounding bone. MAIN TEXT: Implant surfaces composed by biocompatible, organism-fr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894561/ https://www.ncbi.nlm.nih.gov/pubmed/35261541 http://dx.doi.org/10.1186/s42269-022-00743-x |
_version_ | 1784662700424429568 |
---|---|
author | Robo, Ilma Heta, Saimir Papakozma, Dhimitri Ostreni, Vera |
author_facet | Robo, Ilma Heta, Saimir Papakozma, Dhimitri Ostreni, Vera |
author_sort | Robo, Ilma |
collection | PubMed |
description | BACKGROUND: The process of osteointegration, as key point has the activation of mesenchymal cells at implant-bone interspace, their differentiation into osteoblasts and connection between the implant surface and the surrounding bone. MAIN TEXT: Implant surfaces composed by biocompatible, organism-friendly materials require changes in content and surface morphology; changes that may further stimulate mesenchymal cell activation. The way the implant surfaces are affected with advantages and disadvantages, that typically bring each methodology, is also the purpose of this study. The study is of review type, based on finding articles about implant surface modification, with the aim of promoting the mesenchymal cell activation, utilizing keyword combination. CONCLUSIONS: Implant success beyond the human element of the practicioner and the protocol element of implant treatment, also relies on the application of the right type of implant, at the right implant site, in accordance with oral and individual health status of the patient. Implant success does not depend on type of "coating" material of the implants. Based at this physiological process, the success or implant failure is not a process depending on the type of selected implant, because types of synthetic or natural materials that promote osteointegration are relatively in large number. |
format | Online Article Text |
id | pubmed-8894561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88945612022-03-04 Modification of implant surfaces to stimulate mesenchymal cell activation Robo, Ilma Heta, Saimir Papakozma, Dhimitri Ostreni, Vera Bull Natl Res Cent Review BACKGROUND: The process of osteointegration, as key point has the activation of mesenchymal cells at implant-bone interspace, their differentiation into osteoblasts and connection between the implant surface and the surrounding bone. MAIN TEXT: Implant surfaces composed by biocompatible, organism-friendly materials require changes in content and surface morphology; changes that may further stimulate mesenchymal cell activation. The way the implant surfaces are affected with advantages and disadvantages, that typically bring each methodology, is also the purpose of this study. The study is of review type, based on finding articles about implant surface modification, with the aim of promoting the mesenchymal cell activation, utilizing keyword combination. CONCLUSIONS: Implant success beyond the human element of the practicioner and the protocol element of implant treatment, also relies on the application of the right type of implant, at the right implant site, in accordance with oral and individual health status of the patient. Implant success does not depend on type of "coating" material of the implants. Based at this physiological process, the success or implant failure is not a process depending on the type of selected implant, because types of synthetic or natural materials that promote osteointegration are relatively in large number. Springer Berlin Heidelberg 2022-03-04 2022 /pmc/articles/PMC8894561/ /pubmed/35261541 http://dx.doi.org/10.1186/s42269-022-00743-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Robo, Ilma Heta, Saimir Papakozma, Dhimitri Ostreni, Vera Modification of implant surfaces to stimulate mesenchymal cell activation |
title | Modification of implant surfaces to stimulate mesenchymal cell activation |
title_full | Modification of implant surfaces to stimulate mesenchymal cell activation |
title_fullStr | Modification of implant surfaces to stimulate mesenchymal cell activation |
title_full_unstemmed | Modification of implant surfaces to stimulate mesenchymal cell activation |
title_short | Modification of implant surfaces to stimulate mesenchymal cell activation |
title_sort | modification of implant surfaces to stimulate mesenchymal cell activation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894561/ https://www.ncbi.nlm.nih.gov/pubmed/35261541 http://dx.doi.org/10.1186/s42269-022-00743-x |
work_keys_str_mv | AT roboilma modificationofimplantsurfacestostimulatemesenchymalcellactivation AT hetasaimir modificationofimplantsurfacestostimulatemesenchymalcellactivation AT papakozmadhimitri modificationofimplantsurfacestostimulatemesenchymalcellactivation AT ostrenivera modificationofimplantsurfacestostimulatemesenchymalcellactivation |